| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 03/12/2009 | WO2009030715A1 Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions |
| 03/12/2009 | US20090069371 Isoquinoline compounds |
| 03/12/2009 | US20090069282 Alkyne compounds with mch antagonistic activity and medicaments comprising these compounds |
| 03/12/2009 | CA2698486A1 Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions |
| 03/11/2009 | EP2034000A2 Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds |
| 03/11/2009 | EP2033953A1 Vanilloid receptor modulators |
| 03/11/2009 | EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/11/2009 | CN101384555A Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 03/10/2009 | US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/10/2009 | US7501412 e.g. 4-(1-(2-hydroxyethyl)piperidin-4-yl)-2H-isoquinolin-1-one; poly(ADP-ribose)polymerase inhibitor; nicotinamide nucleotide (NAD) substrate; acute cerebral infarction |
| 03/05/2009 | WO2009028972A1 A new inhibitor of dd-peptidase and its use as antibiotic or anticancer drug |
| 03/05/2009 | WO2009028387A1 Therapeutic agent for cancer with resistance to protease inhibitor |
| 03/05/2009 | US20090062530 Substituted arylalkanoic acid derivatives and use thereof |
| 03/05/2009 | US20090062279 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents |
| 03/04/2009 | EP1660443B1 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 03/04/2009 | EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 03/04/2009 | EP1123099B1 Novel indenoisoquinolines as antineoplastic agents |
| 03/03/2009 | US7498441 Melanin-concentrating hormone antagonists for eating disorder and diabetes treatment |
| 03/03/2009 | US7498323 Spiro-piperidine compounds and medicinal use thereof |
| 02/26/2009 | WO2009025914A2 Radiolabelled fluorobenzamide analogues, their synthesis and use in diagnostic imaging |
| 02/26/2009 | WO2009024492A1 Leukotriene b4 inhibitors |
| 02/26/2009 | US20090054420 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 02/26/2009 | CA2696967A1 Leukotriene b4 inhibitors |
| 02/26/2009 | CA2689141A1 Radiolabelled fluorobenzamide analogues, their synthesis and use in diagnostic imaging |
| 02/25/2009 | EP2027087A2 Intracellular kinase inhibitors |
| 02/25/2009 | EP1506188B1 Process for the preparation of a hydrate of an anthranilic acid derivative |
| 02/25/2009 | CN101374815A Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (HIF) |
| 02/24/2009 | US7495098 Dissolving opium in solvent, heating, cooling, adjusting pH with weak acid, filtering; solvent extraction; liquid chromatography |
| 02/24/2009 | US7495012 Arylsulfonamides and uses related thereto |
| 02/24/2009 | US7495011 Anti-coronavirus drug |
| 02/24/2009 | CA2343088C Transfer hydrogenation process |
| 02/19/2009 | US20090048255 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 02/19/2009 | US20090048246 Compounds, compositions and methods for reducing lipid levels |
| 02/19/2009 | US20090048236 New phenylalanine derivatives |
| 02/19/2009 | US20090048224 Compounds and methods of use |
| 02/18/2009 | EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 02/17/2009 | US7491826 Substituted urea derivatives activate the cardiac sarcomere by potentiating cardiac myosin; systolic heart failure including congestive heart failure; 1-[3-(1-Acetyl-piperidin-3-yloxy)-5-fluoro-phenyl]-3-(6-methoxy-pyridin-3-yl)-urea |
| 02/17/2009 | US7491741 Diaminopropionic acid derivatives |
| 02/12/2009 | WO2009020580A1 Gamma secretase modulators |
| 02/12/2009 | WO2009020140A1 Adamantylurea derivative |
| 02/12/2009 | US20090042920 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 02/12/2009 | US20090042862 Novel compounds |
| 02/12/2009 | US20090041663 Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors |
| 02/12/2009 | CA2830727A1 Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| 02/12/2009 | CA2695543A1 Gamma secretase modulators |
| 02/12/2009 | CA2666246A1 Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| 02/11/2009 | CN101365677A Compounds for the treatment of inflammatory disorders and microbial diseases |
| 02/05/2009 | US20090036679 Method for resolving enantiomers from racemic mixture having chiral carbon in alpha position of nitrogen |
| 02/05/2009 | US20090036423 Immunosuppresant compounds and compositions |
| 02/04/2009 | CN101360714A Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies |
| 02/04/2009 | CN100457736C Using alkylmetal reagents for directed metalation of azaaromatics |
| 02/04/2009 | CN100457726C Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes |
| 01/29/2009 | WO2009013299A2 Novel bradykinin b1 antagonists |
| 01/29/2009 | US20090030036 Nuclear receptor binding agents |
| 01/29/2009 | US20090029987 Pharmaceutical Compositions for the Prevention and Treatment of Complex Diseases and Their Delivery by Insertable Medical Devices |
| 01/29/2009 | DE102007034620A1 Neue B1-Antagonisten New B1 antagonists |
| 01/29/2009 | CA2694251A1 Novel b1-antagonists |
| 01/29/2009 | CA2694224A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 01/28/2009 | EP0966443B1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
| 01/28/2009 | CN101356159A Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2H)-isoquinolones and methods of use thereof |
| 01/28/2009 | CN101353324A Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 01/27/2009 | US7482466 Hydroxamates as therapeutic agents |
| 01/27/2009 | US7482437 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/27/2009 | US7482361 Crystalline form for quinapril hydrochloride and process for preparing the same |
| 01/22/2009 | WO2008026075A3 Treatment of intracellular bacterial infections with a protein kinase inhibitor or an as160 polypeptide activator |
| 01/22/2009 | US20090023746 Compounds and their uses 707 |
| 01/22/2009 | US20090023718 Diamine and Iminodiacetic Acid Hydroxamic Acid Derivatives |
| 01/21/2009 | EP2017265A1 Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| 01/21/2009 | EP1663983B1 N-substituted, 6,8-dialkoxy-1,2,3,4-tetrahydro-1h-isoquinoline as potassium channels modulators |
| 01/21/2009 | EP0951466B1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 01/21/2009 | CN101348455A Aspartic acid specificity cysteine proteinase inhibitors and uses thereof |
| 01/21/2009 | CN100453529C Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases |
| 01/15/2009 | WO2009007946A1 Process for producing cisatracurium and associated intermediates |
| 01/15/2009 | WO2009007457A2 Compounds and methods for modulating rho gtpases |
| 01/15/2009 | WO2009007420A1 Novel bronchodilating alpha, beta-unsaturated isoquinoline amides |
| 01/15/2009 | WO2009007419A1 Novel bronchodilating isoquinoline carbamates |
| 01/15/2009 | WO2009007418A1 Novel bronchodilating isoquinoline amides |
| 01/15/2009 | US20090018133 Novel Adamantane Derivatives |
| 01/15/2009 | US20090018116 Therapeutic Compounds |
| 01/15/2009 | US20090017112 Compounds for Inhibiting Beta-Amyloid Production |
| 01/15/2009 | CA2692636A1 Process for producing cisatracurium and associated intermediates |
| 01/15/2009 | CA2692485A1 Compounds and methods for modulating rho gtpases |
| 01/14/2009 | EP2014651A1 Compounds and methods for modulating Rho GTPases |
| 01/14/2009 | EP2014285A1 NPYY5 antagonists |
| 01/14/2009 | EP1478363B1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 01/14/2009 | CN101346353A Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 01/14/2009 | CN100450994C Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 01/13/2009 | US7476686 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea; viricides; Hepatitis C infection |
| 01/13/2009 | US7476679 e.g. N-(4a-(3-Methoxyphenyl)-8a-methyl-2-(3-phenylpropyl)octahydroisoquinolin-6-yl]-3-piperidin-1-yl-propionamide; opioid receptor antagonist; analgesic, antidepressant; nervous system disorder; drug abuse, obesity |
| 01/08/2009 | WO2009005459A1 Phenyl-1,2, 3,4-tetrahydroisoquinolinone derivatives and their use in the treatment of a pain disorder |
| 01/08/2009 | WO2009005045A1 Substituted dihydroisoquinoline derivative |
| 01/08/2009 | WO2008063548A3 5, 6, or 7-substituted-s- (hetero)arylisoquinolinamine derivatives as antitumor agents |
| 01/08/2009 | US20090012097 Polycyclic 1,2,3,4-Tetrahydro-Isoquinoline Derivatives and Compositions Comprising Them As Ppar Modulators |
| 01/07/2009 | EP2010497A1 Compositions and methods for modulating gated ion channels |
| 01/07/2009 | CN101337936A Method for purifying atracurium besylate by column chromatography |
| 01/07/2009 | CN101337935A Method for purifying atracurium besylate by two-phase extraction |
| 12/31/2008 | WO2009001128A1 1,2-cycl0hexane dicarboxamides as cathepsin inhibitors |
| 12/31/2008 | EP2007729A1 Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments |
| 12/30/2008 | US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 12/30/2008 | US7470787 Kinase inhibitors; anticarcinogenic agents; obesity, glaucoma; N-(4-(3-(isoquinolin-6-ylamino)-3-oxopropyl)phenyl)-4-methoxybenzamide |